Valuation: Optiscan Imaging Limited

Market Cap 141M 98.03M 86.32M 81.79M 73.84M 139M 9.4B 979M 377M 4.81B 368M 360M 15.41B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 128M 88.98M 78.36M 74.24M 67.02M 126M 8.53B 888M 342M 4.36B 334M 327M 13.98B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.64%
Yield 2025 *
-
Yield 2026 -
Current month-12.90%
1 month-12.90%
3 months+8.00%
6 months+35.00%
Current year+35.00%
1 week 0.13
Extreme 0.13
0.14
1 month 0.13
Extreme 0.13
0.16
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.26
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 12/12/2021
Director of Finance/CFO - 30/03/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 09/02/2021
Chairman - 18/04/2021
Director/Board Member - 05/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Exercice

Chief Executive Officer

-595,981 0.0571%
14/09/26 Expiration

Chief Executive Officer

-595,981 0.0571%
14/09/26 Exercice

Chief Executive Officer

595,981 0.0571%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+58.82%+84.93% 98.32M
+0.40%+2.21%+40.20%+37.16% 251B
-1.06%+0.25%+12.03%+3.92% 159B
-0.88%+2.67%-8.56%+38.63% 146B
-0.23%-1.52%-54.99%-16.80% 63.59B
-1.60%+0.01%+11.65%+25.51% 50.77B
-0.31%+5.37%+35.71%+57.07% 49.35B
-1.76%+2.07%-17.49%-21.01% 48.75B
+2.66%+5.59%-4.04%+42.10% 45.1B
+0.20%+5.45%+47.93%+63.94% 43.55B
Average -0.27%+2.60%+12.13%+31.55% 85.71B
Weighted average by Cap. -0.31%+3.06%+12.46%+26.01%

Financials

2025 2026
Net sales 3.72M 2.59M 2.28M 2.16M 1.95M 3.68M 248M 25.85M 9.95M 127M 9.72M 9.51M 407M 3.61M 2.51M 2.21M 2.1M 1.89M 3.57M 241M 25.08M 9.65M 123M 9.44M 9.23M 395M
Net income -6.31M -4.39M -3.87M -3.66M -3.31M -6.23M -421M -43.82M -16.86M -215M -16.48M -16.12M -690M -6.99M -4.86M -4.28M -4.05M -3.66M -6.9M -466M -48.5M -18.66M -238M -18.24M -17.84M -763M
Net Debt -3.07M -2.14M -1.88M -1.78M -1.61M -3.03M -205M -21.32M -8.2M -105M -8.02M -7.84M -336M -13.01M -9.05M -7.97M -7.55M -6.81M -12.84M -867M -90.3M -34.75M -443M -33.97M -33.22M -1.42B
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
30/09/26 A$0.1350 0.00% 58,876
29/09/26 A$0.1350 0.00% 119,543
28/09/26 A$0.1350 +3.85% 168,759
24/09/26 A$0.1300 -7.14% 78,099
23/09/26 A$0.1400 +3.70% 29,799